CHO Plus has secured U.S. Patent No. 12,404,502 for a yeast cell–fusion platform designed to create hybrid strains with...

Avicanna has appointed Nick Hilborn, CPA, CA, as interim chief financial officer, effective September 15, 2025, as former CFO...

Virbac reported first-half 2025 results showing steady top-line expansion and softer profitability, while reaffirming full-year guidance and signaling a...

Virbac reported first-half 2025 revenue of €738.3 million, up 5.0% reported and 7.8% at constant exchange rates, with organic...

Theratechnologies shareholders have approved a plan of arrangement under Québec law for the company to be acquired by CB...

Gelteq has moved from development to commercialization in the United States, as products from Healthy Extracts using Gelteq’s proprietary...

BiomX will spotlight positive topline Phase 2 data for BX211, a bacteriophage-based therapy targeting Staphylococcus aureus in diabetic foot...

CorMedix has taken a $5 million strategic minority stake in Talphera, purchasing 9.09 million shares at $0.55 in a...

UroGen Pharma has granted inducement restricted stock units to 40 new employees, issuable for up to 67,700 ordinary shares,...

Ocular Therapeutix will host an Investor Day in New York City on September 30, 2025, centered on Axpaxli, its...